Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B Buse

Showing results (11-20 of 457) with videos related to

Pageof 46
Sort By:
JAMA|October 16, 2019
Reasons for Increases in Complications of DiabetesJohn B Buse
Diabetes Care|December 1, 2010
Clinical care guidelines: too much of a good thing?Deepa Kirk, John B Buse
Endocrinology and Metabolism Clinics of North America|March 9, 2005
Prevention of cardiovascular outcomes in type 2 diabetes mellitus: trials on the horizonJohn B Buse, Julio Rosenstock
Diabetes Care|November 14, 2025
Why Early, Large-scale Weight Loss Is the Future of Type 2 Diabetes CareNaveed Sattar, John B Buse
Metabolism: Clinical and Experimental|July 1, 2019
Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulinAnastasia-Stefania Alexopoulos, John B Buse
Diabetes Care|August 24, 2017
The War Is Not Yet WonLaura A Young, John B Buse
Diabetologia|March 17, 2015
Medications for type 2 diabetes: how will we be treating patients in 50 years?Steven E Kahn, John B Buse
Journal of the American Dental Association (1939)|November 28, 2014
Diabetes and periodontal therapyBruce L Pihlstrom, John B Buse
Annals of Family Medicine|January 16, 2008
Frontline: diabetes--supplementing education and quality improvement in family medicine residency trainingPeter J Carek, John B Buse,
Nature Medicine|May 13, 2022
A new class of drug in the diabetes toolboxKlara R Klein, John B Buse
Pageof 46

Showing results (11-20 of 457) with videos related to

Sort By:
Pageof 46
JAMA|October 16, 2019
Reasons for Increases in Complications of DiabetesJohn B Buse
Diabetes Care|December 1, 2010
Clinical care guidelines: too much of a good thing?Deepa Kirk, John B Buse
Endocrinology and Metabolism Clinics of North America|March 9, 2005
Prevention of cardiovascular outcomes in type 2 diabetes mellitus: trials on the horizonJohn B Buse, Julio Rosenstock
Diabetes Care|November 14, 2025
Why Early, Large-scale Weight Loss Is the Future of Type 2 Diabetes CareNaveed Sattar, John B Buse
Metabolism: Clinical and Experimental|July 1, 2019
Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulinAnastasia-Stefania Alexopoulos, John B Buse
Diabetes Care|August 24, 2017
The War Is Not Yet WonLaura A Young, John B Buse
Diabetologia|March 17, 2015
Medications for type 2 diabetes: how will we be treating patients in 50 years?Steven E Kahn, John B Buse
Journal of the American Dental Association (1939)|November 28, 2014
Diabetes and periodontal therapyBruce L Pihlstrom, John B Buse
Annals of Family Medicine|January 16, 2008
Frontline: diabetes--supplementing education and quality improvement in family medicine residency trainingPeter J Carek, John B Buse,
Nature Medicine|May 13, 2022
A new class of drug in the diabetes toolboxKlara R Klein, John B Buse
Pageof 46